Form 4: Vita Coco CSO Exercises Options, Sells Shares

Vita Coco Company's Chief Sales Officer, Charles van Es, executed a Rule 10b5-1 trading plan, exercising stock options and selling common stock on September 17, 2025.

Summary

• Charles van Es, Chief Sales Officer of Vita Coco Company, Inc. (COCO), engaged in transactions on September 17, 2025.
• Exercised non-qualified stock options to acquire a total of 20,000 shares of common stock at an exercise price of $10.178 per share.
• Sold a total of 20,000 shares of common stock at weighted average prices of $42.04 per share, pursuant to a pre-arranged Rule 10b5-1 trading plan.
• Following these transactions, Charles van Es beneficially owns 84,328 shares of common stock directly.
• Remaining derivative holdings include various non-qualified stock options totaling approximately 238,242 shares, with exercise prices ranging from $10.178 to $33.36 and various vesting schedules and expiration dates up to March 4, 2035.

Sentiment

Score: 5

Explanation: The filing reports routine insider transactions involving option exercise and subsequent share sales under a pre-arranged 10b5-1 plan, which is generally neutral for company sentiment as it is a planned event rather than a reaction to new information.

Positives

• The sale price of $42.04 per share is significantly higher than the exercise price of $10.178 per share, indicating a substantial profit for the officer on the exercised options.

Negatives

• An officer selling a significant number of shares, even under a 10b5-1 plan, could be perceived negatively by some investors as it reduces their direct equity stake in the company.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: The officer's sale, while pre-planned, reduces their direct equity exposure, which some investors might interpret cautiously. However, the execution under a 10b5-1 plan mitigates concerns about opportunistic selling.

Key Dates

Recommendation

The Form 4 details a pre-scheduled insider transaction (option exercise and sale) by a Chief Sales Officer. While the sale reduces the officer's direct holdings, it was executed under a Rule 10b5-1 plan, suggesting it was pre-planned and not based on new material non-public information. Such routine transactions typically do not warrant a change in investment recommendation.

Keywords

Vita Coco, COCO, Charles van Es, Chief Sales Officer, Form 4, Insider Transaction, Stock Options, 10b5-1 Plan, Beneficial Ownership